For M-CLL, one should assess SF3B1, XPO1, NOTCH1 and NFKBIE, while TP53 aberrations do not appear to have any impact on TTFT in this subgroup. The gene discussed is NOTCH1; the disease is B-cell chronic lymphocytic leukemia.